Financials
- Market Capitalization 100.02 M
- Employee 220
- Founded 2002
- CEO N/A
- Website www.exagen.com
- Headquarter Delaware, United States
- FIGI BBG00178FZY1
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3886 | STIM Neuronetics, Inc. - Common Stock | 1.79 USD | +1.70% | +15.48% | +30.66% | -53.75% | 124.56 M USD | ||
| 3923 | BNR Burning Rock Biotech Limited - American Depositary Shares | 10.64 USD | -5.84% | +3.00% | +24.59% | -64.44% | 115.13 M USD | ||
| 4324 | DRIO DarioHealth Corp. - Common Stock | 6.48 USD | -9.37% | -5.81% | -7.56% | -41.99% | 47.38 M USD | ||
| 4365 | PRPO Precipio, Inc. - Common Stock | 24.00 USD | +0.84% | +5.91% | +4.58% | +14.34% | 42.90 M USD |
Frequently asked questions about Exagen Inc. - Common Stock
What is the Exagen Inc. - Common Stock stock price today?
The current price of Exagen Inc. - Common Stock (XGN) is 4.14. Over the past 24 hours, the stock has changed by -6.97%. Follow the XGN chart for real-time price dynamics.
What is the stock ticker of Exagen Inc. - Common Stock?
Exagen Inc. - Common Stock trades under the ticker XGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Exagen Inc. - Common Stock stock going up?
XGN has changed by -5.69% over the last week, -12.84% over the last month, and -41.69% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Exagen Inc. - Common Stock net income for the last quarter?
Exagen Inc. - Common Stock reported net income of -3.97 M for the last quarter. The previous quarter showed -4.67 M, which means net income changed by +15.11%.
How many employees does Exagen Inc. - Common Stock have?
As of the latest available data, Exagen Inc. - Common Stock has 220 employees. Workforce size can provide additional context about the company's scale and operations.
What is Exagen Inc. - Common Stock EBITDA?
Exagen Inc. - Common Stock EBITDA is 4.29 M, and its EBITDA margin is 24.77%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Exagen Inc. - Common Stock stock?
You can buy Exagen Inc. - Common Stock (XGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Exagen Inc. - Common Stock stock?
Investing in Exagen Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XGN chart and related analysis on metatrader.com as part of your research.